Dr. Anand Nadkarni Dr. Anupama Nadkarni
 
 
 
Minimally Invasive Cardiac Surgery (MICS) Surgery
 
Dr Anand Nadkarni is trained in Minimally Invasive Cardiac Surgery, at the Heart center , University of Leipzig Germany. He is actively involved in Academic activity concerning minimally invasive surgery.

Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) is a minimally invasive approach to conventional Coronary Artery Bypass Graft (CABG) surgery. MIDCAB is beating heart surgery, which means that stopping the heart (cardioplegia) is not necessary and a heart-lung machine is not required.

Unlike conventional surgery, which requires a 10"-12" incision to separate the sternum (sternotomy) and places the patient on the heart-lung machine, MICS surgery can be performed through a 3"-5" incision placed between the ribs, or may be done with several small incisions.

MICS surgery results in a faster recovery, fewer complications, and less pain after surgery. It is indicated for use when bypassing one or two coronary arteries. For bypassing three or more arteries, a conventional CABG is indicated.Minimaly Invasive valve surgery can be offered for treating Aortic and Mitral valve disease.


               
 
Potential Patient Benefits of Minimally Invasive Surgery

Minimally invasive surgery is believed to have the same beneficial results as conventional surgery--restoring adequate blood flow and normal delivery of oxygen and nutrients to the heart/valve repair or replacement. Minimally invasive surgery, however, has additional advantages related to the ability of the surgeon to work on a beating heart or through smaller incisions.
  • Shorter length of stay: Patients may experience less pain and may have a better ability to cough and breathe deeply after the operation so they are often discharged from the hospital in 2 to 3 days, compared to the typical 5 to 10 days for conventional CABG surgery.

  • Faster recovery: Avoidance of the heart-lung machine and the use of smaller incisions may reduce the risks of complications such as stroke and renal failure so that patients can return to their normal activities in 2 weeks rather than the typical 6 to 8 weeks with conventional surgery.

  • Less bleeding and blood trauma: Any time blood is removed from the body and put into the heart-lung machine, the patient must be put on anticlotting medications or given "blood products". Artificial circuits such as the heart-lung machine can also damage blood cells. These factors may affect the blood's ability to clot after surgery. Avoiding the heart-lung machine can alleviate this blood trauma.

  • Lower infection rate: A smaller incision means less exposure and handling of tissue, which may reduce the chances of infection.

  • Available to more patients: Some patients are poor candidates for traditional bypass surgery because their illness is too widespread, their heart is too weak, or because they will not accept blood products. Some patients are able to receive this life-saving surgery through minimally invasive techniques.

 
Dr Anand Nadkarni - Minimally Invasive Cardiac Surgery  download the pdf file
 
© Nadkarni Clinic